Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $717.38 million. The enterprise value is $914.23 million.
Important Dates
The next estimated earnings date is Monday, February 3, 2025, before market open.
| Earnings Date | Feb 3, 2025 |
| Ex-Dividend Date | Nov 29, 2024 |
Share Statistics
MLAB has 5.43 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Current Share Class | 5.43M |
| Shares Outstanding | 5.43M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 2.56% |
| Owned by Institutions (%) | 91.47% |
| Float | 5.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 23.25 |
| PS Ratio | 3.12 |
| Forward PS | 2.91 |
| PB Ratio | 4.43 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.05 |
| P/OCF Ratio | 17.88 |
| PEG Ratio | 4.65 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 21.97, with an EV/FCF ratio of 25.55.
| EV / Earnings | n/a |
| EV / Sales | 4.00 |
| EV / EBITDA | 21.97 |
| EV / EBIT | 62.06 |
| EV / FCF | 25.55 |
Financial Position
The company has a current ratio of 0.70, with a Debt / Equity ratio of 1.38.
| Current Ratio | 0.70 |
| Quick Ratio | 0.43 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | 4.88 |
| Debt / FCF | 6.23 |
| Interest Coverage | 1.53 |
Financial Efficiency
Return on equity (ROE) is -89.46% and return on invested capital (ROIC) is 1.94%.
| Return on Equity (ROE) | -89.46% |
| Return on Assets (ROA) | 1.69% |
| Return on Capital (ROIC) | 1.94% |
| Revenue Per Employee | $310,299 |
| Profits Per Employee | -$333,765 |
| Employee Count | 736 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.66 |
Taxes
| Income Tax | -20.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.79% in the last 52 weeks. The beta is 0.86, so MLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +25.79% |
| 50-Day Moving Average | 120.63 |
| 200-Day Moving Average | 113.75 |
| Relative Strength Index (RSI) | 61.90 |
| Average Volume (20 Days) | 44,519 |
Short Selling Information
The latest short interest is 148,303, so 2.73% of the outstanding shares have been sold short.
| Short Interest | 148,303 |
| Short Previous Month | 122,974 |
| Short % of Shares Out | 2.73% |
| Short % of Float | 2.80% |
| Short Ratio (days to cover) | 3.64 |
Income Statement
In the last 12 months, MLAB had revenue of $228.38 million and -$245.65 million in losses. Loss per share was -$45.50.
| Revenue | 228.38M |
| Gross Profit | 145.12M |
| Operating Income | 14.73M |
| Pretax Income | -270.81M |
| Net Income | -245.65M |
| EBITDA | 41.61M |
| EBIT | 14.73M |
| Loss Per Share | -$45.50 |
Full Income StatementBalance Sheet
The company has $26.00 million in cash and $222.86 million in debt, giving a net cash position of -$196.85 million or -$36.24 per share.
| Cash & Cash Equivalents | 26.00M |
| Total Debt | 222.86M |
| Net Cash | -196.85M |
| Net Cash Per Share | -$36.24 |
| Equity (Book Value) | 161.45M |
| Book Value Per Share | 29.79 |
| Working Capital | -45.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $40.12 million and capital expenditures -$4.34 million, giving a free cash flow of $35.78 million.
| Operating Cash Flow | 40.12M |
| Capital Expenditures | -4.34M |
| Free Cash Flow | 35.78M |
| FCF Per Share | $6.59 |
Full Cash Flow StatementMargins
Gross margin is 63.54%, with operating and profit margins of 6.45% and -107.56%.
| Gross Margin | 63.54% |
| Operating Margin | 6.45% |
| Pretax Margin | -116.33% |
| Profit Margin | -107.56% |
| EBITDA Margin | 18.22% |
| EBIT Margin | 6.45% |
| FCF Margin | 15.67% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.48%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.48% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.70% |
| Shareholder Yield | -0.21% |
| Earnings Yield | -34.24% |
| FCF Yield | 4.99% |
Dividend DetailsAnalyst Forecast
The average price target for MLAB is $140.00, which is 6.00% higher than the current price. The consensus rating is "Hold".
| Price Target | $140.00 |
| Price Target Difference | 6.00% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.1 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.1 |
| Piotroski F-Score | 6 |